| Title |
Drug Companies’ Liability for the Opioid Epidemic
|
|---|---|
| Published in |
New England Journal of Medicine, December 2017
|
| DOI | 10.1056/nejmp1710756 |
| Pubmed ID | |
| Authors |
Rebecca L Haffajee, Michelle M Mello |
X Demographics
The data shown below were collected from the profiles of 382 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 144 | 38% |
| Canada | 18 | 5% |
| Spain | 8 | 2% |
| United Kingdom | 8 | 2% |
| Australia | 3 | <1% |
| Mexico | 3 | <1% |
| Germany | 2 | <1% |
| Thailand | 2 | <1% |
| Sweden | 1 | <1% |
| Other | 17 | 4% |
| Unknown | 176 | 46% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 299 | 78% |
| Practitioners (doctors, other healthcare professionals) | 37 | 10% |
| Scientists | 32 | 8% |
| Science communicators (journalists, bloggers, editors) | 14 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 122 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 20 | 16% |
| Researcher | 10 | 8% |
| Student > Master | 10 | 8% |
| Student > Ph. D. Student | 9 | 7% |
| Student > Doctoral Student | 7 | 6% |
| Other | 20 | 16% |
| Unknown | 46 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 21% |
| Social Sciences | 8 | 7% |
| Nursing and Health Professions | 7 | 6% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Other | 20 | 16% |
| Unknown | 51 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 863. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2024.
All research outputs
#21,299
of 25,882,826 outputs
Outputs from New England Journal of Medicine
#894
of 32,727 outputs
Outputs of similar age
#408
of 447,182 outputs
Outputs of similar age from New England Journal of Medicine
#23
of 270 outputs
Altmetric has tracked 25,882,826 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,727 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 123.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,182 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 270 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.